Duponte Clinical Research and Biomedical Innovation Programme 2026
Closed
Deadline: -
Funding body:
Duponte
The aim of this call is to promote research projects with a major impact on clinical practice that contribute to the advancement of personalised medicine, with particular attention to genomic alterations and the development of new technologies and therapeutic strategies.
The priority areas are: Genomics, bioinformatics, clinical pharmacogenomics and rare diseases.
Projects must correspond to the following types of activity:
● Translational research.
● Clinical research.
● Technological development and biomedical innovation.
● Computational and bioinformatics analysis.
The duration of the project will be established by Duponte in the grant award decision, in accordance with the planning and implementation needs of the funded proposal.
Indirect costs of 15% must be included in the budget.
Applicants must submit their application before 12:00 noon on 11 September, together with the evaluation application form, for assessment by the iiSGM Research Committee email link(ELIMINAR).